Vibcare Pharma is the Leading PCD Pharma Company in India

Posted October 14, 2019 by vibcare

Based out of Panchkula, Haryana, Vibcare Pharma has emerged as the leading PCD pharma company in India, thanks to its quality backed focus and customer-centricity.

Vibcare Pharma is a widely recognized brand, dedicatedly providing safe, effective and low-cost drugs across all therapeutic segments. The pharma company has a state-of-the-art facility in Panchkula where production is done in line with GMP and ISO 9001:2015 quality management standards. The end products are sold across India, Africa, CIS and South Asia at the best prices through a flourishing PCD network comprised of pharmacy dealers, pharma distributors and medical representatives. Vibcare Pharma keeps bringing qualitative improvement in products, processes and systems continuously to meet international norms in safety and effectiveness.

The spokesperson at Vibcare Pharma recently stated, “Vibcare Pharma has a glorious past and a promising future. We are in business since the 1970s and since then have shaped a reputation on quality, variety and prices. Our WHO-GMP Certified facility features 6 main divisions that together produce over 700 generic drugs for over 1,216 customers internationally. Our efficiency in providing on-time, in the budget, integrated third party manufacturing is second to none. Add to a thriving PCD network, we are one of the top brands in the highly competitive healthcare segment. We are here for the long haul, poised to deliver the best solutions.”

Vibcare Pharma’s focus is on delivering generic drugs for all medical conditions, age groups and occupations. The Prima and Auspin divisions are committed to providing medications for virtually all general disorders while Cure Division ensures symptom relief from heart conditions and diabetes. Grace Division continues to support the needs of beauty-savvy people with generic medications for all skin conditions. Likewise, the Mind and Optho Divisions produce drugs to cater to the Neuropsychiatry and Ophthalmic needs respectively in all targeted markets. Besides safety and effectiveness, affordability is the other common element across all drugs.

On PCD programs on offer, the spokesperson further stated, “Going with the best PCD pharma network has its benefits, as our PCD franchisees will attest to. We offer a highly lucrative, growth oriented PCD pharma program for forward-looking dealers, distributors and MRs nationally. Our broad product portfolio backed by quality assurance is there to help franchisees stay competitive in their resale markets while our best pricing ensures high profitability. Besides, we provide marketing support and promotional material like a visual aid, prescription pads, LBL, reminder cards, pen, keychain, gifts, and more are also provided free of cost.”

Vibcare Pharma knows the importance of swift and reliable deliveries for PCD franchisees. Accordingly, the pharma company has ties with DTDC International, TCI Freight, Trackon Couriers, and other top-rated carriers for nationwide deliveries in fast turnaround times. Plus, Vibcare Pharma offers dedicated customer support, should the franchisee need any help at any given time. As one of the best Pharma Franchise Companies, Vibcare Pharma ensures complete transparency, providing all business-related information upfront.

About Vibcare Pharma:

Based in Panchkula, Haryana, Vibcare Pharma is among the leading pharma companies in India. The pharma company is associated with an extensive, safe and easy to use and low-cost portfolio of drugs for all therapeutic segments. Presently, Vibcare Pharma is the top source for those looking for PCD Pharma Company in India.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Vibcare Pharma Pvt. Ltd.
Phone +91-988-898-8858
Business Address Plot No. 4, HSIIDC IT Park, Sector 22, Panchkula, Haryana – 134109
Country India
Categories Health
Tags best pharma franchise companies , looking for pcd pharma company
Last Updated October 14, 2019